TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

[Display omitted]

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2023-03, Vol.141 (9), p.1087-1091
Hauptverfasser:	Hiwase, Devendra, Hahn, Christopher, Tran, Elizabeth Ngoc Hoa, Chhetri, Rakchha, Baranwal, Anmol, Al-Kali, Aref, Sharplin, Kirsty, Ladon, Dariusz, Hollins, Rachel, Greipp, Patricia, Kutyna, Monika, Alkhateeb, Hassan, Badar, Talha, Wang, Paul, Ross, David M., Singhal, Deepak, Shanmuganathan, Naranie, Bardy, Peter, Beligaswatte, Ashanka, Yeung, David, Litzow, Mark R., Mangaonkar, Abhishek, Giri, Pratyush, Lee, Cindy, Yong, Angie, Horvath, Noemi, Singhal, Nimit, Gowda, Raghu, Hogan, William, Gangat, Naseema, Patnaik, Mrinal, Begna, Kebede, Tiong, Ing S., Wei, Andrew, Kumar, Sharad, Brown, Anna, Scott, Hamish, Thomas, Daniel, Kok, Chung H., Tefferi, Ayalew, Shah, Mithun Vinod
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - therapy Mutation Myeloproliferative Disorders - genetics Tumor Suppressor Protein p53 - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!